Divis Laboratories Complete Financial Statements
DIVISLAB • Review detailed financials to uncover trends, confirm thesis & journal trades
11 Years of Data
2025 - 2015
Complete Financial Data Export
Export complete financial statements for Divis Laboratories (DIVISLAB).
Downloads include all available records across all periods.
For market performance, see the
DIVISLAB stock price today
.
Profitability Ratios
Net Profit Margin
24.09%
2025 data
EBITDA Margin
36.12%
2025 data
Operating Margin
33.00%
2025 data
Return on Assets
4.07%
2025 data
Return on Equity
4.60%
2025 data
Balance Sheet Ratios
Current Ratio
19.73
2025 data
Debt to Equity
1.13
2025 data
Equity Ratio
88.41%
2025 data
Asset Turnover
0.17
2025 data
Year-over-Year Growth Analysis
Comparing Sept 2024 vs Sept 2025
Revenue Growth
+17.0%
Year-over-Year
Net Profit Growth
+35.1%
Year-over-Year
EBITDA Growth
+25.7%
Year-over-Year
Expense Growth
+12.6%
Year-over-Year
Assets Growth
+9.5%
Year-over-Year
Equity Growth
+10.3%
Year-over-Year
Liabilities Growth
+9.5%
Year-over-Year
Operating Cash Flow Growth
+31.1%
Year-over-Year
Investing Cash Flow Growth
-198.9%
Year-over-Year
Income Statement
Periods
₹ Crores
| Particulars | Sept 2025 | Mar 2025 | Jun 2025 | Sept 2024 | Mar 2024 | Jun 2024 | Dec 2024 | Sept 2023 | Mar 2023 | Jun 2023 | Dec 2023 | Sept 2022 | Mar 2022 | Jun 2022 | Dec 2022 | Sept 2021 | Mar 2021 | Jun 2021 | Dec 2021 | Sept 2020 | Mar 2020 | Jun 2020 | Dec 2020 | Sept 2019 | Mar 2019 | Jun 2019 | Dec 2019 | Sept 2018 | Jun 2018 | Dec 2018 | Mar 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 2,860 | 2,671 | 2,529 | 2,444 | 2,382 | 2,197 | 2,401 | 1,995 | 2,017 | 1,859 | 1,950 | 1,935 | 2,571 | 2,343 | 1,821 | 2,007 | 1,812 | 1,997 | 2,510 | 1,763 | 1,466 | 1,748 | 1,721 | 1,493 | 1,308 | 1,193 | 1,438 | 1,404 | 1,044 | 1,394 | 830 |
| Expenses | 1,827 | 1,699 | 1,681 | 1,622 | 1,572 | 1,496 | 1,576 | 1,430 | 1,464 | 1,274 | 1,366 | 1,234 | 1,414 | 1,406 | 1,299 | 1,169 | 1,072 | 1,109 | 1,396 | 1,008 | 945 | 1,030 | 1,010 | 955 | 851 | 776 | 902 | 802 | 643 | 827 | 501 |
| EBITDA | 1,033 | 972 | 848 | 822 | 810 | 701 | 825 | 565 | 553 | 585 | 584 | 701 | 1,157 | 937 | 522 | 837 | 740 | 888 | 1,114 | 755 | 521 | 717 | 711 | 538 | 457 | 418 | 536 | 602 | 401 | 567 | 328 |
| Operating Profit Margin % | 33.00% | 34.00% | 30.00% | 31.00% | 32.00% | 29.00% | 32.00% | 25.00% | 25.00% | 28.00% | 26.00% | 33.00% | 44.00% | 38.00% | 24.00% | 41.00% | 40.00% | 43.00% | 44.00% | 42.00% | 32.00% | 40.00% | 41.00% | 34.00% | 33.00% | 33.00% | 35.00% | 39.00% | 35.00% | 39.00% | 39.00% |
| Depreciation | 113 | 107 | 112 | 99 | 95 | 97 | 99 | 95 | 87 | 93 | 95 | 86 | 81 | 85 | 87 | 77 | 70 | 73 | 80 | 61 | 50 | 56 | 68 | 46 | 42 | 44 | 47 | 42 | 42 | 43 | 45 |
| Interest | 8 | 1 | 3 | 1 | 2 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 4 | 0 | 0 | 2 | 0 | 1 | 3 | 1 |
| Profit Before Tax | 912 | 864 | 733 | 722 | 713 | 604 | 726 | 469 | 466 | 492 | 489 | 615 | 1,076 | 852 | 435 | 760 | 670 | 815 | 1,034 | 694 | 471 | 661 | 642 | 488 | 415 | 373 | 487 | 559 | 359 | 522 | 286 |
| Tax | 223 | 202 | 188 | 212 | 175 | 174 | 137 | 121 | 145 | 136 | 131 | 122 | 181 | 150 | 129 | 153 | 168 | 257 | 131 | 174 | 83 | 169 | 172 | 131 | 123 | 101 | 128 | 156 | 91 | 133 | 54 |
| Net Profit | 689 | 662 | 545 | 510 | 538 | 430 | 589 | 348 | 321 | 356 | 358 | 493 | 895 | 702 | 306 | 607 | 502 | 557 | 902 | 520 | 388 | 492 | 471 | 357 | 292 | 272 | 359 | 404 | 268 | 389 | 232 |
| Earnings Per Share (₹) | 25.97 | 24.93 | 20.49 | 19.20 | 20.25 | 16.20 | 22.20 | 13.11 | 12.09 | 13.41 | 13.50 | 18.60 | 33.70 | 26.44 | 11.56 | 22.84 | 18.91 | 20.99 | 33.99 | 19.57 | 14.62 | 18.54 | 17.73 | 13.44 | 11.00 | 10.26 | 13.53 | 15.21 | 10.08 | 14.67 | 17.40 |
Related Pages for Divis Laboratories
Additional stock information and data for DIVISLAB
Balance Sheet
Years
Annual Data
₹ Crores
| Particulars | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||||
| Total Assets | 16,932 | 15,470 | 14,439 | 13,375 | 10,774 | 8,536 | 8,038 | 6,786 | 6,159 | 4,902 | 4,411 |
| Current Assets | 10,081 | 9,675 | 9,312 | 8,352 | 6,175 | 4,680 | 4,650 | 4,535 | 4,011 | 3,027 | 2,772 |
| Fixed Assets | 5,442 | 4,739 | 4,723 | 4,325 | 3,704 | 2,782 | 2,088 | 1,996 | 1,559 | 1,439 | 1,309 |
| Capital Work in Progress | 1,022 | 778 | 212 | 470 | 711 | 920 | 492 | 120 | 444 | 264 | 218 |
| Investments | 65 | 82 | 77 | 72 | 0 | 971 | 1,946 | 1,889 | 1,631 | 803 | 733 |
| Other Assets | 10,403 | 9,871 | 9,427 | 8,508 | 6,360 | 3,863 | 3,513 | 2,781 | 2,525 | 2,397 | 2,151 |
| LIABILITIES | |||||||||||
| Total Liabilities | 16,932 | 15,470 | 14,439 | 13,375 | 10,774 | 8,536 | 8,038 | 6,786 | 6,159 | 4,902 | 4,411 |
| Current Liabilities | 511 | 621 | 571 | 451 | 367 | 299 | 234 | 208 | 142 | 89 | 141 |
| Non-Current Liabilities | |||||||||||
| SHAREHOLDERS' EQUITY | |||||||||||
| Total Equity | 14,969 | 13,571 | 12,767 | 11,728 | 9,295 | 7,310 | 6,957 | 5,925 | 5,357 | 4,293 | 3,495 |
| Share Capital | 53 | 53 | 53 | 53 | 53 | 53 | 53 | 53 | 53 | 53 | 27 |
| Reserves & Surplus | 14,916 | 13,518 | 12,714 | 11,675 | 9,242 | 7,257 | 6,904 | 5,872 | 5,304 | 4,240 | 3,469 |
Cash Flow Statement
Periods
₹ Crores
| Particulars | March 2025 | March 2024 | March 2023 | March 2022 | March 2021 | March 2020 | March 2019 | March 2018 | March 2017 | March 2016 | March 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | 1,653 | 1,261 | 2,460 | 1,912 | 1,947 | 1,216 | 954 | 776 | 1,150 | 1,038 | 826 |
| Investing Activities | -804 | -269 | -2,708 | -2,195 | 75 | -84 | -685 | -478 | -1,140 | -406 | -521 |
| Financing Activities | -799 | -799 | -797 | -532 | -35 | -1,091 | -246 | -314 | 2 | -631 | -303 |
| Net Cash Flow | 50 | 193 | -1,045 | -816 | 1,987 | 41 | 23 | -17 | 13 | 0 | 3 |